Inspirion Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$537K	Sell	9,283 -45	-0.5%	-$2.46K	0.06%	110
2026 Q1	$527K	Buy	9,328 +4,000	+75%	+$233K	0.07%	102
2025 Q4	$317K	Sell	5,328 -8,130	-60%	-$443K	0.04%	134
2025 Q3	$946K	Buy	13,458 +7,148	+113%	+$409K	0.13%	62
2025 Q2	$347K	Sell	6,310 -10	-0.2%	-$589	0.05%	119
2025 Q1	$447K	Buy	6,320 +725	+13%	+$48.8K	0.06%	102
2024 Q4	$380K	Sell	5,595 -7,863	-58%	-$527K	0.05%	110
2024 Q3	$946K	Hold	13,458	–	–	0.13%	62
2024 Q2	$1.11M	Buy	13,458 +504	+4%	+$42K	0.17%	53
2024 Q1	$1.13M	Buy	12,954 +71	+0.6%	+$6.36K	0.19%	54
2023 Q4	$1.26M	Buy	12,883 +260	+2%	+$23K	0.23%	48
2023 Q3	$1.12M	Buy	12,623 +725	+6%	+$64.5K	0.22%	48
2023 Q2	$1.03M	Buy	11,898 +58	+0.5%	+$5.46K	0.2%	53
2023 Q1	$1.15M	Hold	11,840	–	–	0.23%	44
2022 Q4	$1.23M	Buy	11,840 +1,000	+9%	+$93.9K	0.26%	40
2022 Q3	$919K	Buy	10,840 +450	+4%	+$40.1K	0.21%	48
2022 Q2	$861K	Buy	10,390 +2,564	+33%	+$204K	0.19%	54
2022 Q1	$603K	Buy	7,826 +2,300	+42%	+$192K	0.12%	60
2021 Q4	$488K	Sell	5,526 -129	-2%	-$10.6K	0.1%	62
2021 Q3	$437K	Buy	5,655 +557	+11%	+$43.9K	0.1%	62
2021 Q2	$425K	Buy	5,098 +44	+0.9%	+$3.49K	0.1%	61
2021 Q1	$382K	Buy	+5,054	New	+$413K	0.1%	65

Other funds holding BMRN